164 related articles for article (PubMed ID: 38216945)
1. Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.
Chu Z; Jia L; Dai J; Wu Q; Tian F; Bai S
J Ovarian Res; 2024 Jan; 17(1):16. PubMed ID: 38216945
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
Front Public Health; 2021; 9():688264. PubMed ID: 34485218
[No Abstract] [Full Text] [Related]
5. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
[No Abstract] [Full Text] [Related]
6. [Efficacy of dienogest versus gonadotropin-releasing hormone agonist combined with dienogest sequential therapy in the treatment of adenomyosis].
Zhang HY; Zhu S; Xu W; Wang AQ; Wang XL
Zhonghua Fu Chan Ke Za Zhi; 2022 Nov; 57(11):856-863. PubMed ID: 36456483
[No Abstract] [Full Text] [Related]
7. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
Peng Y; Dai Y; Yu G; Yang X; Wen C; Jin P
Int J Hyperthermia; 2021; 38(1):1271-1275. PubMed ID: 34423729
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL; Wang XX; Nie ML; Huang XH
Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
[TBL] [Abstract][Full Text] [Related]
10. [Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility].
Zhou LM; Zheng J; Sun YT; Zhao YY; Xia AL
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):334-7. PubMed ID: 24016474
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
Ye MZ; Deng XL; Zhu XG; Xue M
Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
[No Abstract] [Full Text] [Related]
12. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
Yang X; Zhang X; Lin B; Feng X; Aili A
Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
[TBL] [Abstract][Full Text] [Related]
13. [Acupuncture combined with medication improves endocrine hormone levels and ovarian reserve function in poor ovarian response patients undergoing in vitro fertilization-embryo transplantation].
Dong XL; Ran JK; Zhang HJ; Chen K; Li HX
Zhen Ci Yan Jiu; 2019 Aug; 44(8):599-604. PubMed ID: 31475495
[TBL] [Abstract][Full Text] [Related]
14. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
Wang L; Zhang WX; Jiang H
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of medical treatment for adenomyosis after adenomyomectomy.
Li Q; Yuan M; Li N; Zhen Q; Chen C; Wang G
J Obstet Gynaecol Res; 2020 Oct; 46(10):2092-2099. PubMed ID: 32725682
[TBL] [Abstract][Full Text] [Related]
16. Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients.
Huang BS; Seow KM; Tsui KH; Huang CY; Lu YF; Wang PH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):212-6. PubMed ID: 22795096
[TBL] [Abstract][Full Text] [Related]
17. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
[TBL] [Abstract][Full Text] [Related]
18. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Wu J; Huang Y; Chen L; Hu J; Zou Y
Med Sci Monit; 2018 Sep; 24():6085-6092. PubMed ID: 30171680
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]